Global Molecular Diagnostics Systems Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Molecular Diagnostics Systems Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 PCR
1.2.3 Hybridization
1.2.4 DNA Sequencing
1.3 Market Segment by Application
1.3.1 Global Molecular Diagnostics Systems Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospitals
1.3.3 Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Molecular Diagnostics Systems Market Size (2017-2028)
2.1.1 Global Molecular Diagnostics Systems Revenue (2017-2028)
2.1.2 Global Molecular Diagnostics Systems Sales (2017-2028)
2.2 Global Molecular Diagnostics Systems Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Molecular Diagnostics Systems Sales by Regions (2017-2022)
2.2.2 Global Molecular Diagnostics Systems Revenue by Regions (2017-2022)
2.3 Global Molecular Diagnostics Systems Market Size Forecast by Region
2.3.1 Global Molecular Diagnostics Systems Sales Forecast by Region (2023-2028)
2.3.2 Global Molecular Diagnostics Systems Revenue Forecast by Region (2023-2028)
2.4 Global Top Molecular Diagnostics Systems Regions (Countries) Ranking by Market Size
2.5 Molecular Diagnostics Systems Market Dynamics
2.5.1 Molecular Diagnostics Systems Market Trends
2.5.2 Molecular Diagnostics Systems Market Drivers
2.5.3 Molecular Diagnostics Systems Market Challenges
2.5.4 Molecular Diagnostics Systems Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Molecular Diagnostics Systems Manufacturers by Sales (2017-2022)
3.1.1 Global Molecular Diagnostics Systems Sales by Manufacturers (2017-2022)
3.1.2 Global Molecular Diagnostics Systems Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Molecular Diagnostics Systems Sales in 2021
3.2 Global Top Manufacturers Molecular Diagnostics Systems by Revenue
3.2.1 Global Molecular Diagnostics Systems Revenue by Manufacturers (2017-2022)
3.2.2 Top Molecular Diagnostics Systems Manufacturers Covered: Ranking by Revenue
3.2.3 Global Molecular Diagnostics Systems Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Molecular Diagnostics Systems Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Molecular Diagnostics Systems as of 2021)
3.4 Global Molecular Diagnostics Systems Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Molecular Diagnostics Systems Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Molecular Diagnostics Systems Market
3.7 Key Manufacturers Molecular Diagnostics Systems Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Molecular Diagnostics Systems Market Size by Type
4.1 Global Molecular Diagnostics Systems Historic Market Review by Type (2017-2022)
4.1.1 Global Molecular Diagnostics Systems Sales Market Share by Type (2017-2022)
4.1.2 Global Molecular Diagnostics Systems Revenue Market Share by Type (2017-2022)
4.1.3 Molecular Diagnostics Systems Price by Type (2017-2022)
4.2 Global Molecular Diagnostics Systems Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Molecular Diagnostics Systems Sales Forecast by Type (2023-2028)
4.2.2 Global Molecular Diagnostics Systems Revenue Forecast by Type (2023-2028)
4.2.3 Molecular Diagnostics Systems Price Forecast by Type (2023-2028)
5 Global Molecular Diagnostics Systems Market Size by Application
5.1 Global Molecular Diagnostics Systems Historic Market Review by Application (2017-2022)
5.1.1 Global Molecular Diagnostics Systems Sales Market Share by Application (2017-2022)
5.1.2 Global Molecular Diagnostics Systems Revenue Market Share by Application (2017-2022)
5.1.3 Molecular Diagnostics Systems Price by Application (2017-2022)
5.2 Global Molecular Diagnostics Systems Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Molecular Diagnostics Systems Sales Forecast by Application (2023-2028)
5.2.2 Global Molecular Diagnostics Systems Revenue Forecast by Application (2023-2028)
5.2.3 Molecular Diagnostics Systems Price Forecast by Application (2023-2028)
6 North America
6.1 North America Molecular Diagnostics Systems Sales Breakdown by Company
6.1.1 North America Molecular Diagnostics Systems Sales by Company (2017-2022)
6.1.2 North America Molecular Diagnostics Systems Revenue by Company (2017-2022)
6.2 North America Molecular Diagnostics Systems Market Size by Type
6.2.1 North America Molecular Diagnostics Systems Sales by Type (2017-2028)
6.2.2 North America Molecular Diagnostics Systems Revenue by Type (2017-2028)
6.3 North America Molecular Diagnostics Systems Market Size by Application
6.3.1 North America Molecular Diagnostics Systems Sales by Application (2017-2028)
6.3.2 North America Molecular Diagnostics Systems Revenue by Application (2017-2028)
6.4 North America Molecular Diagnostics Systems Market Size by Country
6.4.1 North America Molecular Diagnostics Systems Sales by Country (2017-2028)
6.4.2 North America Molecular Diagnostics Systems Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Molecular Diagnostics Systems Sales Breakdown by Company
7.1.1 Europe Molecular Diagnostics Systems Sales by Company (2017-2022)
7.1.2 Europe Molecular Diagnostics Systems Revenue by Company (2017-2022)
7.2 Europe Molecular Diagnostics Systems Market Size by Type
7.2.1 Europe Molecular Diagnostics Systems Sales by Type (2017-2028)
7.2.2 Europe Molecular Diagnostics Systems Revenue by Type (2017-2028)
7.3 Europe Molecular Diagnostics Systems Market Size by Application
7.3.1 Europe Molecular Diagnostics Systems Sales by Application (2017-2028)
7.3.2 Europe Molecular Diagnostics Systems Revenue by Application (2017-2028)
7.4 Europe Molecular Diagnostics Systems Market Size by Country
7.4.1 Europe Molecular Diagnostics Systems Sales by Country (2017-2028)
7.4.2 Europe Molecular Diagnostics Systems Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Molecular Diagnostics Systems Sales Breakdown by Company
8.1.1 Asia Pacific Molecular Diagnostics Systems Sales by Company (2017-2022)
8.1.2 Asia Pacific Molecular Diagnostics Systems Revenue by Company (2017-2022)
8.2 Asia Pacific Molecular Diagnostics Systems Market Size by Type
8.2.1 Asia Pacific Molecular Diagnostics Systems Sales by Type (2017-2028)
8.2.2 Asia Pacific Molecular Diagnostics Systems Revenue by Type (2017-2028)
8.3 Asia Pacific Molecular Diagnostics Systems Market Size by Application
8.3.1 Asia Pacific Molecular Diagnostics Systems Sales by Application (2017-2028)
8.3.2 Asia Pacific Molecular Diagnostics Systems Revenue by Application (2017-2028)
8.4 Asia Pacific Molecular Diagnostics Systems Market Size by Region
8.4.1 Asia Pacific Molecular Diagnostics Systems Sales by Region
8.4.2 Asia Pacific Molecular Diagnostics Systems Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Molecular Diagnostics Systems Sales Breakdown by Company
9.1.1 Latin America Molecular Diagnostics Systems Sales by Company (2017-2022)
9.1.2 Latin America Molecular Diagnostics Systems Revenue by Company (2017-2022)
9.2 Latin America Molecular Diagnostics Systems Market Size by Type
9.2.1 Latin America Molecular Diagnostics Systems Sales by Type (2017-2028)
9.2.2 Latin America Molecular Diagnostics Systems Revenue by Type (2017-2028)
9.3 Latin America Molecular Diagnostics Systems Market Size by Application
9.3.1 Latin America Molecular Diagnostics Systems Sales by Application (2017-2028)
9.3.2 Latin America Molecular Diagnostics Systems Revenue by Application (2017-2028)
9.4 Latin America Molecular Diagnostics Systems Market Size by Country
9.4.1 Latin America Molecular Diagnostics Systems Sales by Country (2017-2028)
9.4.2 Latin America Molecular Diagnostics Systems Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Molecular Diagnostics Systems Sales Breakdown by Company
10.1.1 Middle East and Africa Molecular Diagnostics Systems Sales by Company (2017-2022)
10.1.2 Middle East and Africa Molecular Diagnostics Systems Revenue by Company (2017-2022)
10.2 Middle East and Africa Molecular Diagnostics Systems Market Size by Type
10.2.1 Middle East and Africa Molecular Diagnostics Systems Sales by Type (2017-2028)
10.2.2 Middle East and Africa Molecular Diagnostics Systems Revenue by Type (2017-2028)
10.3 Middle East and Africa Molecular Diagnostics Systems Market Size by Application
10.3.1 Middle East and Africa Molecular Diagnostics Systems Sales by Application (2017-2028)
10.3.2 Middle East and Africa Molecular Diagnostics Systems Revenue by Application (2017-2028)
10.4 Middle East and Africa Molecular Diagnostics Systems Market Size by Country
10.4.1 Middle East and Africa Molecular Diagnostics Systems Sales by Country (2017-2028)
10.4.2 Middle East and Africa Molecular Diagnostics Systems Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Overview
11.1.3 Abbott Laboratories Molecular Diagnostics Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Abbott Laboratories Molecular Diagnostics Systems Products and Services
11.1.5 Abbott Laboratories Molecular Diagnostics Systems SWOT Analysis
11.1.6 Abbott Laboratories Recent Developments
11.2 Qiagen N.V.
11.2.1 Qiagen N.V. Corporation Information
11.2.2 Qiagen N.V. Overview
11.2.3 Qiagen N.V. Molecular Diagnostics Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Qiagen N.V. Molecular Diagnostics Systems Products and Services
11.2.5 Qiagen N.V. Molecular Diagnostics Systems SWOT Analysis
11.2.6 Qiagen N.V. Recent Developments
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Corporation Information
11.3.2 Roche Diagnostics Overview
11.3.3 Roche Diagnostics Molecular Diagnostics Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Roche Diagnostics Molecular Diagnostics Systems Products and Services
11.3.5 Roche Diagnostics Molecular Diagnostics Systems SWOT Analysis
11.3.6 Roche Diagnostics Recent Developments
11.4 Hologic, Inc.
11.4.1 Hologic, Inc. Corporation Information
11.4.2 Hologic, Inc. Overview
11.4.3 Hologic, Inc. Molecular Diagnostics Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Hologic, Inc. Molecular Diagnostics Systems Products and Services
11.4.5 Hologic, Inc. Molecular Diagnostics Systems SWOT Analysis
11.4.6 Hologic, Inc. Recent Developments
11.5 Grifols
11.5.1 Grifols Corporation Information
11.5.2 Grifols Overview
11.5.3 Grifols Molecular Diagnostics Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Grifols Molecular Diagnostics Systems Products and Services
11.5.5 Grifols Molecular Diagnostics Systems SWOT Analysis
11.5.6 Grifols Recent Developments
11.6 Siemens Healthcare
11.6.1 Siemens Healthcare Corporation Information
11.6.2 Siemens Healthcare Overview
11.6.3 Siemens Healthcare Molecular Diagnostics Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Siemens Healthcare Molecular Diagnostics Systems Products and Services
11.6.5 Siemens Healthcare Molecular Diagnostics Systems SWOT Analysis
11.6.6 Siemens Healthcare Recent Developments
11.7 Becton, Dickinson and Company
11.7.1 Becton, Dickinson and Company Corporation Information
11.7.2 Becton, Dickinson and Company Overview
11.7.3 Becton, Dickinson and Company Molecular Diagnostics Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Becton, Dickinson and Company Molecular Diagnostics Systems Products and Services
11.7.5 Becton, Dickinson and Company Molecular Diagnostics Systems SWOT Analysis
11.7.6 Becton, Dickinson and Company Recent Developments
11.8 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
11.8.1 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Corporation Information
11.8.2 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Overview
11.8.3 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Products and Services
11.8.5 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems SWOT Analysis
11.8.6 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Recent Developments
11.9 Biomérieux Sa
11.9.1 Biomérieux Sa Corporation Information
11.9.2 Biomérieux Sa Overview
11.9.3 Biomérieux Sa Molecular Diagnostics Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Biomérieux Sa Molecular Diagnostics Systems Products and Services
11.9.5 Biomérieux Sa Molecular Diagnostics Systems SWOT Analysis
11.9.6 Biomérieux Sa Recent Developments
11.10 Cepheid Inc
11.10.1 Cepheid Inc Corporation Information
11.10.2 Cepheid Inc Overview
11.10.3 Cepheid Inc Molecular Diagnostics Systems Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Cepheid Inc Molecular Diagnostics Systems Products and Services
11.10.5 Cepheid Inc Molecular Diagnostics Systems SWOT Analysis
11.10.6 Cepheid Inc Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Molecular Diagnostics Systems Value Chain Analysis
12.2 Molecular Diagnostics Systems Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Molecular Diagnostics Systems Production Mode & Process
12.4 Molecular Diagnostics Systems Sales and Marketing
12.4.1 Molecular Diagnostics Systems Sales Channels
12.4.2 Molecular Diagnostics Systems Distributors
12.5 Molecular Diagnostics Systems Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of TablesTable 1. Global Molecular Diagnostics Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of PCR
Table 3. Major Manufacturers of Hybridization
Table 4. Major Manufacturers of DNA Sequencing
Table 5. Global Molecular Diagnostics Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Molecular Diagnostics Systems Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Molecular Diagnostics Systems Sales by Region (2017-2022) & (K Units)
Table 8. Global Molecular Diagnostics Systems Sales Market Share by Region (2017-2022)
Table 9. Global Molecular Diagnostics Systems Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Molecular Diagnostics Systems Revenue Market Share by Region (2017-2022)
Table 11. Global Molecular Diagnostics Systems Sales Forecast by Region (2023-2028) & (K Units)
Table 12. Global Molecular Diagnostics Systems Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Molecular Diagnostics Systems Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Molecular Diagnostics Systems Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Molecular Diagnostics Systems Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Molecular Diagnostics Systems Market Trends
Table 17. Molecular Diagnostics Systems Market Drivers
Table 18. Molecular Diagnostics Systems Market Challenges
Table 19. Molecular Diagnostics Systems Market Restraints
Table 20. Global Molecular Diagnostics Systems Sales by Manufacturers (2017-2022) & (K Units)
Table 21. Global Molecular Diagnostics Systems Sales Share by Manufacturers (2017-2022)
Table 22. Global Molecular Diagnostics Systems Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Molecular Diagnostics Systems Manufacturers by Revenue (US$ Million) in 2021
Table 24. Molecular Diagnostics Systems Revenue Share by Manufacturers (2017-2022)
Table 25. Global Molecular Diagnostics Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Molecular Diagnostics Systems as of 2021)
Table 27. Key Manufacturers Molecular Diagnostics Systems Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 28. Key Manufacturers Molecular Diagnostics Systems Plants/Factories Distribution
Table 29. Key Manufacturers Molecular Diagnostics Systems Area Served
Table 30. Date of Key Manufacturers Enter into Molecular Diagnostics Systems Market
Table 31. Key Manufacturers Molecular Diagnostics Systems Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Molecular Diagnostics Systems Sales (K Units) by Type (2017-2022)
Table 34. Global Molecular Diagnostics Systems Sales Share by Type (2017-2022)
Table 35. Global Molecular Diagnostics Systems Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Molecular Diagnostics Systems Price (K Units) by Type (2017-2022)
Table 37. Global Molecular Diagnostics Systems Sales (K Units) by Type (2023-2028)
Table 38. Global Molecular Diagnostics Systems Sales Share by Type (2023-2028)
Table 39. Global Molecular Diagnostics Systems Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Molecular Diagnostics Systems Revenue Share by Type (2023-2028)
Table 41. Global Molecular Diagnostics Systems Price (K Units) by Type (2023-2028)
Table 42. Global Molecular Diagnostics Systems Sales (K Units) by Application (2017-2022)
Table 43. Global Molecular Diagnostics Systems Sales Share by Application (2017-2022)
Table 44. Global Molecular Diagnostics Systems Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Molecular Diagnostics Systems Price (K Units) by Application (2017-2022)
Table 46. Global Molecular Diagnostics Systems Sales (K Units) by Application (2023-2028)
Table 47. Global Molecular Diagnostics Systems Sales Share by Application (2023-2028)
Table 48. Global Molecular Diagnostics Systems Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Molecular Diagnostics Systems Revenue Share by Application (2023-2028)
Table 50. Global Molecular Diagnostics Systems Price (K Units) by Application (2023-2028)
Table 51. North America Molecular Diagnostics Systems Sales by Company (2017-2022) & (K Units)
Table 52. North America Molecular Diagnostics Systems Sales Market Share by Company (2017-2022)
Table 53. North America Molecular Diagnostics Systems Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Molecular Diagnostics Systems Revenue Market Share by Company (2017-2022)
Table 55. North America Molecular Diagnostics Systems Sales by Type (2017-2022) & (K Units)
Table 56. North America Molecular Diagnostics Systems Sales by Type (2023-2028) & (K Units)
Table 57. North America Molecular Diagnostics Systems Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Molecular Diagnostics Systems Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Molecular Diagnostics Systems Sales by Application (2017-2022) & (K Units)
Table 60. North America Molecular Diagnostics Systems Sales by Application (2023-2028) & (K Units)
Table 61. North America Molecular Diagnostics Systems Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Molecular Diagnostics Systems Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Molecular Diagnostics Systems Sales by Country (2017-2022) & (K Units)
Table 64. North America Molecular Diagnostics Systems Sales by Country (2023-2028) & (K Units)
Table 65. North America Molecular Diagnostics Systems Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Molecular Diagnostics Systems Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Molecular Diagnostics Systems Sales by Company (2017-2022) & (K Units)
Table 68. Europe Molecular Diagnostics Systems Sales Market Share by Company (2017-2022)
Table 69. Europe Molecular Diagnostics Systems Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Molecular Diagnostics Systems Revenue Market Share by Company (2017-2022)
Table 71. Europe Molecular Diagnostics Systems Sales by Type (2017-2022) & (K Units)
Table 72. Europe Molecular Diagnostics Systems Sales by Type (2023-2028) & (K Units)
Table 73. Europe Molecular Diagnostics Systems Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Molecular Diagnostics Systems Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Molecular Diagnostics Systems Sales by Application (2017-2022) & (K Units)
Table 76. Europe Molecular Diagnostics Systems Sales by Application (2023-2028) & (K Units)
Table 77. Europe Molecular Diagnostics Systems Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Molecular Diagnostics Systems Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Molecular Diagnostics Systems Sales by Country (2017-2022) & (K Units)
Table 80. Europe Molecular Diagnostics Systems Sales by Country (2023-2028) & (K Units)
Table 81. Europe Molecular Diagnostics Systems Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Molecular Diagnostics Systems Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Molecular Diagnostics Systems Sales by Company (2017-2022) & (K Units)
Table 84. Asia Pacific Molecular Diagnostics Systems Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Molecular Diagnostics Systems Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Molecular Diagnostics Systems Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Molecular Diagnostics Systems Sales by Type (2017-2022) & (K Units)
Table 88. Asia Pacific Molecular Diagnostics Systems Sales by Type (2023-2028) & (K Units)
Table 89. Asia Pacific Molecular Diagnostics Systems Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Molecular Diagnostics Systems Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Molecular Diagnostics Systems Sales by Application (2017-2022) & (K Units)
Table 92. Asia Pacific Molecular Diagnostics Systems Sales by Application (2023-2028) & (K Units)
Table 93. Asia Pacific Molecular Diagnostics Systems Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Molecular Diagnostics Systems Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Molecular Diagnostics Systems Sales by Region (2017-2022) & (K Units)
Table 96. Asia Pacific Molecular Diagnostics Systems Sales by Region (2023-2028) & (K Units)
Table 97. Asia Pacific Molecular Diagnostics Systems Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Molecular Diagnostics Systems Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Molecular Diagnostics Systems Sales by Company (2017-2022) & (K Units)
Table 100. Latin America Molecular Diagnostics Systems Sales Market Share by Company (2017-2022)
Table 101. Latin America Molecular Diagnostics Systems Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Molecular Diagnostics Systems Revenue Market Share by Company (2017-2022)
Table 103. Latin America Molecular Diagnostics Systems Sales by Type (2017-2022) & (K Units)
Table 104. Latin America Molecular Diagnostics Systems Sales by Type (2023-2028) & (K Units)
Table 105. Latin America Molecular Diagnostics Systems Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Molecular Diagnostics Systems Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Molecular Diagnostics Systems Sales by Application (2017-2022) & (K Units)
Table 108. Latin America Molecular Diagnostics Systems Sales by Application (2023-2028) & (K Units)
Table 109. Latin America Molecular Diagnostics Systems Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Molecular Diagnostics Systems Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Molecular Diagnostics Systems Sales by Country (2017-2022) & (K Units)
Table 112. Latin America Molecular Diagnostics Systems Sales by Country (2023-2028) & (K Units)
Table 113. Latin America Molecular Diagnostics Systems Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Molecular Diagnostics Systems Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Molecular Diagnostics Systems Sales by Company (2017-2022) & (K Units)
Table 116. Middle East and Africa Molecular Diagnostics Systems Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Molecular Diagnostics Systems Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Molecular Diagnostics Systems Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Molecular Diagnostics Systems Sales by Type (2017-2022) & (K Units)
Table 120. Middle East and Africa Molecular Diagnostics Systems Sales by Type (2023-2028) & (K Units)
Table 121. Middle East and Africa Molecular Diagnostics Systems Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Molecular Diagnostics Systems Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Molecular Diagnostics Systems Sales by Application (2017-2022) & (K Units)
Table 124. Middle East and Africa Molecular Diagnostics Systems Sales by Application (2023-2028) & (K Units)
Table 125. Middle East and Africa Molecular Diagnostics Systems Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Molecular Diagnostics Systems Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Molecular Diagnostics Systems Sales by Country (2017-2022) & (K Units)
Table 128. Middle East and Africa Molecular Diagnostics Systems Sales by Country (2023-2028) & (K Units)
Table 129. Middle East and Africa Molecular Diagnostics Systems Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Molecular Diagnostics Systems Revenue by Country (2023-2028) & (US$ Million)
Table 131. Abbott Laboratories Corporation Information
Table 132. Abbott Laboratories Description and Overview
Table 133. Abbott Laboratories Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 134. Abbott Laboratories Molecular Diagnostics Systems Product and Services
Table 135. Abbott Laboratories Molecular Diagnostics Systems SWOT Analysis
Table 136. Abbott Laboratories Recent Developments
Table 137. Qiagen N.V. Corporation Information
Table 138. Qiagen N.V. Description and Overview
Table 139. Qiagen N.V. Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 140. Qiagen N.V. Molecular Diagnostics Systems Product and Services
Table 141. Qiagen N.V. Molecular Diagnostics Systems SWOT Analysis
Table 142. Qiagen N.V. Recent Developments
Table 143. Roche Diagnostics Corporation Information
Table 144. Roche Diagnostics Description and Overview
Table 145. Roche Diagnostics Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 146. Roche Diagnostics Molecular Diagnostics Systems Product and Services
Table 147. Roche Diagnostics Molecular Diagnostics Systems SWOT Analysis
Table 148. Roche Diagnostics Recent Developments
Table 149. Hologic, Inc. Corporation Information
Table 150. Hologic, Inc. Description and Overview
Table 151. Hologic, Inc. Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 152. Hologic, Inc. Molecular Diagnostics Systems Product and Services
Table 153. Hologic, Inc. Molecular Diagnostics Systems SWOT Analysis
Table 154. Hologic, Inc. Recent Developments
Table 155. Grifols Corporation Information
Table 156. Grifols Description and Overview
Table 157. Grifols Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 158. Grifols Molecular Diagnostics Systems Product and Services
Table 159. Grifols Molecular Diagnostics Systems SWOT Analysis
Table 160. Grifols Recent Developments
Table 161. Siemens Healthcare Corporation Information
Table 162. Siemens Healthcare Description and Overview
Table 163. Siemens Healthcare Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 164. Siemens Healthcare Molecular Diagnostics Systems Product and Services
Table 165. Siemens Healthcare Molecular Diagnostics Systems SWOT Analysis
Table 166. Siemens Healthcare Recent Developments
Table 167. Becton, Dickinson and Company Corporation Information
Table 168. Becton, Dickinson and Company Description and Overview
Table 169. Becton, Dickinson and Company Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 170. Becton, Dickinson and Company Molecular Diagnostics Systems Product and Services
Table 171. Becton, Dickinson and Company Molecular Diagnostics Systems SWOT Analysis
Table 172. Becton, Dickinson and Company Recent Developments
Table 173. Beckman Coulter Inc. (A Wholly Owned Subsidiary